Daniel B. Costa

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Lung cancer with EGFR PACC mutations: a practical review of available treatment options and novel therapies on the horizon

  Translational Lung Cancer Research · 2026-05-01

• Coopting Germline BRCA2 Mutation With an Available PARP Inhibitor to Manage Resistance to EGFR Targeted Therapy in EGFR-Mutated Lung Cancer: Combination of Olaparib With Osimertinib

  Clinical Lung Cancer · 2026-02-25

• A Comprehensive Mutational and Histopathological Analysis of STK11-Mutant Non–Small Cell Lung Carcinomas

  Modern Pathology · 2025-11-20 · 1 citations

• Análise Comparativa de LLMs na Otimização de Índices em Banco de Dados: Um Estudo com GPT-4, Claude 3.7 Sonnet e Gemini 2.0 Flash

  2025-07-20

• The EQUAL study: Utilizing plasma EGFR cfDNA detection as an accessible screening tool for lung cancer in underserved patients ineligible for routine screening.

  Journal of Clinical Oncology · 2025-05-28 · 1 citations

• Real world efficacy of dose-reduced capmatinib and tepotinib for advanced MET exon 14–skipping+ NSCLC.

  Journal of Clinical Oncology · 2025-05-28 · 1 citations

• Antimicrobial resistance and treatment failures in symptomatic and asymptomatic <i>Mycoplasma genitalium</i> infections in São Paulo, Brazil: first evidence from a cross-sectional study of sexual health clinic attendees

  Sexually Transmitted Infections · 2025-05-16

• Patterns of HER2 expression and genomic correlates in lung cancer, with a focus on preanalytical variables impacting immunohistochemical staining results

  Journal of Clinical Pathology · 2025-03-12 · 1 citations

• Efficacy of EGFR tyrosine kinase inhibitors in patients with non–small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry)

  Lung Cancer · 2025-03-05

• EPIDEMIOLOGICAL ANALYSIS OF BREAST CANCER IN A REFERENCE HOSPITAL IN BELÉM DO PARÁ BETWEEN 2021 AND 2022

  2025-01-01

• How to select between osimertinib or afatinib in P-loop and αC-helix compressing (G719X, S768I) or classical-like (L861Q) EGFR mutations: what preclinical models and clinical data have taught us in the early 2020s

  Translational Cancer Research · 2025-01-01 · 1 citations

• Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors

  Lung Cancer · 2024-11-15 · 6 citations

• P1.12A.02 Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with NSCLC Harboring EGFR Exon 19 Insertions: A Report from the LC-SCRUM-Asia

  Journal of Thoracic Oncology · 2024-10-01

• Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology‐proven malignant pleural effusions

  Cancer Cytopathology · 2024-08-29 · 2 citations

• Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer

  Cell Death and Disease · 2024-08-09 · 18 citations

• Targeting of drug-tolerant persister cells as an approach to counter drug resistance in non-small cell lung cancer

  Lung Cancer · 2024-07-08 · 13 citations